目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value
3.2. Market volume

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?

8 Company Profiles
8.1. Teva Pharmaceutical Industries Ltd
8.2. Viatris Inc
8.3. Lupin Ltd
8.4. Aspen Pharmacare Holdings Ltd

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Australia generics market value: $ million, 2018-23
Table 2: Australia generics market volume: % of total pharma volume, 2018-23
Table 3: Australia generics market geography segmentation: $ million, 2023
Table 4: Australia generics market value forecast: $ million, 2023-28
Table 5: Australia generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Teva Pharmaceutical Industries Ltd: Key Facts
Table 7: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Ltd: Key Employees
Table 9: Viatris Inc: Key Facts
Table 10: Viatris Inc: Annual Financial Ratios
Table 11: Viatris Inc: Key Employees
Table 12: Lupin Ltd: Key Facts
Table 13: Lupin Ltd: Annual Financial Ratios
Table 14: Lupin Ltd: Key Employees
Table 15: Aspen Pharmacare Holdings Ltd: Key Facts
Table 16: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 17: Aspen Pharmacare Holdings Ltd: Key Employees
Table 18: Australia Size of Population (million), 2019-23
Table 19: Australia Real GDP (Constant 2010 Prices, $ Billion), 2019-23
Table 20: Australia GDP (Current Prices, $ Billion), 2019-23
Table 21: Australia Inflation, 2019-23
Table 22: Australia Consumer Price Index (Absolute), 2019-23
Table 23: Australia Exchange Rate, 2018-23

List of Figures
Figure 1: Australia generics market value: $ million, 2018-23
Figure 2: Australia generics market volume: % of total pharma volume, 2018-23
Figure 3: Australia generics market geography segmentation: % share, by value, 2023
Figure 4: Australia generics market value forecast: $ million, 2023-28
Figure 5: Australia generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in Australia, 2023
Figure 7: Drivers of buyer power in the generics market in Australia, 2023
Figure 8: Drivers of supplier power in the generics market in Australia, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Australia, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in Australia, 2023
Figure 11: Drivers of degree of rivalry in the generics market in Australia, 2023